Abnormalities of protein kinases in neurodegenerative diseases

R T Wagey1, C Krieger

  • 1Dept. of Medicine, University of British Columbia, Vancouver, Canada.

Insights

Protein kinase dysregulation in neurodegenerative diseases like ALS and AD may cause abnormal phosphorylation, potentially driving disease progression. Further research using model systems is crucial for understanding these complex mechanisms.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease (AD), exhibit evidence of abnormal protein kinase regulation.
  • Altered kinase activity and protein levels in these diseases suggest aberrant phosphorylation, a potential contributor to pathogenesis.
  • Dysfunctional NMDA receptor regulation in ALS patients may stem from altered phosphorylation of associated protein kinases.

Purpose of the Study:

  • To investigate the role of protein kinase signaling in the pathogenesis of neurodegenerative diseases like ALS and AD.
  • To elucidate the relationship between protein kinase abnormalities and NMDA receptor function in ALS.
  • To explore the complexity of pathogenic mechanisms and cell death pathways in ALS and AD.

Main Methods:

  • Review of existing evidence on protein kinase regulation in neurodegenerative diseases.
  • Analysis of altered kinase activities and protein levels.
  • Consideration of NMDA receptor function in ALS patient tissue.
  • Discussion of potential model systems for further study.

Main Results:

  • Evidence suggests abnormal protein kinase regulation and aberrant phosphorylation in ALS and AD.
  • Altered NMDA receptor regulation in ALS may be linked to aberrant phosphorylation.
  • The precise role of kinase abnormalities (primary, secondary, or compensatory) remains unclear.
  • Pathogenic mechanisms and cell death pathways in ALS and AD are complex and potentially overlapping.

Conclusions:

  • Impaired protein kinase signaling is implicated in neurodegenerative diseases, but its exact role is debated.
  • Understanding the interplay between protein kinases, NMDA receptors, and cell death is critical.
  • Further investigation using diverse model systems is necessary to unravel the complexities of ALS and AD pathogenesis.

Related Concept Videos

Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...